Skip to content

Biodesix, Inc. BDSX Other income, net (Note 6)

Other income, net (Note 6) at other companies

NeoGenomics logo
NeoGenomicsNEO
-$12K-118%
Veracyte logo
VeracyteVCYT
$7.33M+62.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20K+143%
Guardant Health logo
Guardant HealthGH
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s other income, net (note 6)?
Biodesix, Inc. (BDSX) reported other income, net (note 6) of $385K in Q1 2026.
How has Biodesix, Inc.'s other income, net (note 6) changed year-over-year?
Biodesix, Inc.'s other income, net (note 6) increased by 292.9% year-over-year, from $98K to $385K.
What is the long-term trend for Biodesix, Inc.'s other income, net (note 6)?
Over 2 years (2021 to 2023), Biodesix, Inc.'s other income, net (note 6) has grown at a 120.7% compound annual growth rate (CAGR), from -$2.22M to -$10.8M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.